Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy

Authors

  • Christel Depienne,

    Corresponding author
    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Département de Génétique, Cytogénétique et Embryologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    3. Université Pierre et Marie Curie, Faculté de Médecine, Paris, France
    • INSERM U679, Groupe Hospitalier Pitié-Salpêtrière, 47 Boulevard de L'hôpital, 75013 Paris, France
    Search for more papers by this author
  • Alexis Arzimanoglou,

    1. Unité d'Epileptologie Pédiatrique, Service de Neurologie Pédiatrique et des Maladies Métaboliques, Hôpital Robert Debré, AP-HP, Paris, France
    Search for more papers by this author
  • Oriane Trouillard,

    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Département de Génétique, Cytogénétique et Embryologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Estelle Fedirko,

    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Département de Génétique, Cytogénétique et Embryologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Stéphanie Baulac,

    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Université Pierre et Marie Curie, Faculté de Médecine, Paris, France
    Search for more papers by this author
  • Cécile Saint-Martin,

    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Université Pierre et Marie Curie, Faculté de Médecine, Paris, France
    Search for more papers by this author
  • Merle Ruberg,

    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Université Pierre et Marie Curie, Faculté de Médecine, Paris, France
    Search for more papers by this author
  • Charlotte Dravet,

    1. Centre Saint-Paul, Hôpital Henri Gastaut, Marseille, France
    Search for more papers by this author
  • Rima Nabbout,

    1. Service de Neuropédiatrie, Hôpital Necker, Paris; France
    Search for more papers by this author
  • Michel Baulac,

    1. Université Pierre et Marie Curie, Faculté de Médecine, Paris, France
    2. Pôle d'Epileptologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Isabelle Gourfinkel-An,

    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Pôle d'Epileptologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    Search for more papers by this author
  • Eric Leguern

    1. INSERM U679 (formerly U289), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    2. Département de Génétique, Cytogénétique et Embryologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    3. Université Pierre et Marie Curie, Faculté de Médecine, Paris, France
    Search for more papers by this author

Abstract

De novo mutations in the SCN1A gene, encoding the alpha1-subunit of the neuronal voltage-gated sodium channel Nav1.1, are the most frequent genetic cause of Severe Myoclonic Epilepsy of Infancy known so far. A few mutations inherited from an asymptomatic or mildly affected parent have been reported, suggesting that expression of the mutated gene may be variable in the transmitting parent. In this study, we report two unrelated families in which two children of unaffected parents had deleterious SCN1A mutations, and show evidence of somatic and germline mosaicism in the transmitting parents. In one of these families, direct sequencing of blood cell DNA was not sufficient to the SCN1A mutation in the transmitting asymptomatic parent who was mosaic for the mutation. We therefore developed a real-time PCR assay to selectively amplify and quantify the mutant allele present at low levels in the transmitting parent in both families. The allele-specific PCR technique used in this study will be of use in detecting other such cases. These findings will have major consequences for the genetic counseling of asymptomatic parents with only one affected child. © 2006 Wiley-Liss, Inc.

Ancillary